Unveiling 4 Analyst Insights On AnaptysBio
Unveiling 4 Analyst Insights On AnaptysBio
公布关于AnaptysBio的4项分析师见解
In the preceding three months, 4 analysts have released ratings for AnaptysBio (NASDAQ:ANAB), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有4位分析师发布了AnaptysBio（纳斯达克股票代码：ANAB）的评级，提出了从看涨到看跌的各种观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天中情绪的变化，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for AnaptysBio, revealing an average target of $53.25, a high estimate of $80.00, and a low estimate of $28.00. Surpassing the previous average price target of $30.00, the current average has increased by 77.5%.
分析师已经为AnaptysBio设定了12个月的目标股价，显示平均目标股价为53.25美元，最高估计为80.00美元，低估值为28.00美元。超过了之前的30.00美元的平均目标价，目前的平均价格上涨了77.5％。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细明细
An in-depth analysis of recent analyst actions...
对分析师近期行为...
登录免费看全文
登录/注册